|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.737
|
Human |
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.561
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.475
|
|
|
|
4 hydroxyproline metabolic process
|
GO:0019471 |
5 |
0.471
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.411
|
|
|
|
coenzyme biosynthetic process
|
GO:0009108 |
23 |
0.360
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.242
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.202
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.201
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.191
|
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
41 |
0.156
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.152
|
Human |
|
|
acyl coa metabolic process
|
GO:0006637 |
19 |
0.137
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.128
|
Human |
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.115
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.110
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.106
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.104
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.099
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.095
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.088
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.085
|
|
|
|
succinyl coa metabolic process
|
GO:0006104 |
1 |
0.080
|
|
|
|
tricarboxylic acid metabolic process
|
GO:0072350 |
5 |
0.076
|
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
18 |
0.076
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.075
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.074
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.073
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.071
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.071
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.066
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.063
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.062
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.058
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.058
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.058
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.056
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.056
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.055
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.053
|
|
|
|
iron sulfur cluster assembly
|
GO:0016226 |
3 |
0.052
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.050
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.049
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.048
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.048
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.046
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.046
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.046
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.045
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.044
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.042
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.042
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.042
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.040
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.039
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.038
|
|
|
|
acetyl coa biosynthetic process from pyruvate
|
GO:0006086 |
3 |
0.037
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.036
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.036
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.036
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.035
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.034
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.034
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.033
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.033
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.033
|
|
|
|
quinone metabolic process
|
GO:1901661 |
7 |
0.033
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.032
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.031
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.030
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.030
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
acetyl coa biosynthetic process
|
GO:0006085 |
5 |
0.029
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.028
|
|
|
|
metallo sulfur cluster assembly
|
GO:0031163 |
3 |
0.028
|
|
|
|
thioester metabolic process
|
GO:0035383 |
19 |
0.028
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.027
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.027
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.027
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.026
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.026
|
|
|
|
ubiquinone biosynthetic process
|
GO:0006744 |
4 |
0.026
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.026
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.026
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.026
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.026
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.026
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.025
|
|
|
|
acyl coa biosynthetic process
|
GO:0071616 |
7 |
0.025
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.024
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.024
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.024
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.024
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.024
|
|
|
|
succinate metabolic process
|
GO:0006105 |
4 |
0.023
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.023
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.023
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.023
|
|
|
|
quinone biosynthetic process
|
GO:1901663 |
4 |
0.023
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.023
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.022
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.022
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.022
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.021
|
|
|
|
regulation of atp biosynthetic process
|
GO:2001169 |
3 |
0.021
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.021
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.021
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.021
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.020
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.020
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.020
|
|
|
|
oxidative phosphorylation
|
GO:0006119 |
14 |
0.020
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.020
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.020
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.019
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.019
|
|
|
|
age dependent general metabolic decline
|
GO:0007571 |
3 |
0.019
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.019
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.019
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.019
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.018
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.018
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.018
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.018
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.018
|
|
|
|
water soluble vitamin metabolic process
|
GO:0006767 |
10 |
0.017
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.017
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.017
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.017
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.017
|
|
|
|
age dependent response to oxidative stress
|
GO:0001306 |
3 |
0.017
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.017
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.017
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.016
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.016
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.016
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.016
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.016
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.016
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.016
|
|
|
|
water soluble vitamin biosynthetic process
|
GO:0042364 |
3 |
0.015
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.015
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.015
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.015
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.015
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.015
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.015
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.015
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.015
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.015
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.015
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.015
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.015
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.015
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.015
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.015
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.014
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.014
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.014
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.014
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.014
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.014
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.014
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
19 |
0.014
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
11 |
0.014
|
Worm |
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.014
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.014
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.014
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.013
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.013
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.013
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.013
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
tetrapyrrole biosynthetic process
|
GO:0033014 |
16 |
0.013
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.013
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.013
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.013
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.013
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.013
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.013
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.013
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.013
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.012
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.012
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.012
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.012
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.012
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.012
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.012
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.012
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.012
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.012
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.012
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.012
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.012
|
|
|
|
aerobic respiration
|
GO:0009060 |
7 |
0.012
|
Human |
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.012
|
|
|
|
negative regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031665 |
3 |
0.012
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.012
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.012
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.012
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.012
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.011
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.011
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.011
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.011
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.011
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.011
|
|
|
|
glycosyl compound biosynthetic process
|
GO:1901659 |
21 |
0.011
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.011
|
|
|
|
thioester biosynthetic process
|
GO:0035384 |
7 |
0.011
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.011
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
|
atp synthesis coupled electron transport
|
GO:0042773 |
8 |
0.011
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.011
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.011
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.011
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.011
|
|
|
|
protein export from nucleus
|
GO:0006611 |
20 |
0.011
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.011
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.011
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.011
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.010
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.010
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.010
|
|
|
|
nadh metabolic process
|
GO:0006734 |
1 |
0.010
|
|
|
|
protein oxidation
|
GO:0018158 |
2 |
0.010
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.010
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.010
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.010
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.010
|
|
|
|
regulation of male germ cell proliferation
|
GO:2000254 |
3 |
0.010
|
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
16 |
0.010
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.010
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.010
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.010
|
|